Login  
Volume 67
March 2006
Number 3

Academic Highlights   [top]

478  Academic Highlights: Review of the Pharmacologic Management of Depression.[CME]

[Full Text]

Editorial   [top]

341  Editorial: Circle of Honor

[Full Text]

Original Articles   [top]

342  Neural Correlates of the Affect Regulation Model in Schizophrenia Patients With Substance Use History: A Functional Magnetic Resonance Imaging Study

[Full Text]

351  Association Between Attention-Deficit/Hyperactivity Disorder and Bulimia Nervosa: Analysis of 4 Case-Control Studies.

[Full Text]

355  Quetiapine in the Treatment of Anxiety in Patients With Bipolar I or II Depression: A Secondary Analysis From a Randomized, Double-Blind, Placebo-Controlled Study.

[Full Text]

363  The Epidemiology of DSM-IV Panic Disorder and Agoraphobia in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

[Full Text]

375  A Pilot Study on Differences in Aggression in New York City and Madrid, Spain, and Their Possible Impact on Suicidal Behavior.

[Full Text]

381  An Open-Label Trial of Risperidone Augmentation for Refractory Anxiety Disorders

[Full Text]

386  Use of Treatment Services and Pharmacotherapy for Bipolar Disorder in a General Population-Based Mental Health Survey.

[Full Text]

393  Exacerbation of PTSD Symptoms With Use of Duloxetine

[Full Text]

394  Persistent Posttraumatic Stress Disorder Following September 11 in Patients With Bipolar Disorder

[Full Text]

400  The Effect of Dermatologic Precautions on the Incidence of Rash With Addition of Lamotrigine in the Treatment of Bipolar I Disorder: A Randomized Trial

[Full Text]

407  Selective Serotonin Reuptake Inhibitors in Autism: A Review of Efficacy and Tolerability.

[Full Text]

415  Atomoxetine and Adult Attention-Deficit/Hyperactivity Disorder: The Effects of Comorbidity.

[Full Text]

421  Effect of Mirtazapine Treatment on Body Composition and Metabolism

[Full Text]

425  Sociodemographic Characteristics and Cardiovascular Risk Factors in Patients With Severe Mental Disorders Compared With the General Population.[CME]

[Full Text]

434  Distinguishing Bipolar Major Depression From Unipolar Major Depression With the Screening Assessment of Depression-Polarity (SAD-P)

[Full Text]

443  Psychoeducation and Compliance in the Treatment of Schizophrenia: Results of the Munich Psychosis Information Project Study.

[Full Text]

453  Medication Adherence and Long-Term Functional Outcomes in the Treatment of Schizophrenia in Usual Care

[Full Text]

461  The Effects of Long-Term Clozapine Add-On Therapy on the Rehospitalization Rate and the Mood Polarity Patterns in Bipolar Disorders

[Full Text]

468  Outcomes of Late-Life Anxiety Disorders During 32 Weeks of Citalopram Treatment

[Full Text]

473  A Double-Blind, Randomized, Placebo-Controlled, Prophylaxis Study of Adjunctive Gabapentin for Bipolar Disorder

[Full Text]

ASCP Corner   [top]

490  ASCP Corner: Use of Atypical Antipsychotics: Observations From Clinical Practice

[Full Text]

Letters to the Editor   [top]

492  Toxic Catatonia Secondary to Azithromycin

[Full Text]

493  3-Acetyl-7-Oxo-Dehydroepiandrosterone for Healing Treatment-Resistant Posttraumatic Stress Disorder in Women: 5 Case Reports

[Full Text]

497  Methodological Issues in a Study of Long-Term Maintenance Therapy With Quetiapine Versus Haloperidol Decanoate

[Full Text]

497  Drs. Glick and Marder Reply

[Full Text]

Book Reviews   [top]

499  Fear and Anxiety: The Benefits of Translational Research

[Full Text]



information for authors

see www.psychiatrist.com/pages/author.aspx